Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery
Information source: Kuopio University Hospital
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Atrial Fibrillation; Cardiac Surgery
Intervention: metoprolol, amiodarone (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Kuopio University Hospital Overall contact:
Jari Halonen, MD, Phone: +358405885829, Email: jari.halonen@kuh.fi
Summary
The aim of the study is to test the efficiency of intravenous administration of metoprolol
versus intravenous administration of amiodarone in the prevention of atrial fibrillation
after cardiac surgery.
Clinical Details
Official title: Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery
Study design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Primary outcome: Incidence of atrial fibrillation
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- elective CABG and aortic valve patients in cardiac surgery,
- previous use of betablocker therapy
Exclusion Criteria:
- previous atrial fibrillation or flutter,
- thyroid disease,
- uncontrolled heart failure,
- II or III degree atrioventricular block
Locations and Contacts
Jari Halonen, MD, Phone: +358405885829, Email: jari.halonen@kuh.fi
Halonen jari, Kuopio FIN- 70211, Finland; Recruiting
Jari Halonen, MD, Phone: +358405885829, Email: jari.halonen@kuh.fi
Additional Information
Starting date: August 2007
Ending date: December 2008
Last updated: August 10, 2009
|
